1 - 25 of 1
Number of results to display per page
TitleDateType
1 A phase 1 double-blind comparison of the safety and tolerance of eight percent arildone (win 30820) to the ninety percent DMSO/ten percent PEG-400 vehicle during and following seven day topical application to immunocompromised patients1983-05Text
1 - 25 of 1